Want to join the conversation?
$VRTX 2Q15 Q&A: Geoffrey of Barclays clarified if Vertex was rethinking some of the endpoints overall for development beyond FEV1, and Jeffrey Leiden said the company is eager to explore additional endpoints to FEV1, particularly for younger populations where it is more difficult to consistently blow a good FEV1 if one is 2/3-years-old.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?